Report

Global Chemiluminescence Immunoassay Market Size study, by Product (Instruments, Consumables, Software & Services) End-use (Hospitals, clinical laboratories, pharmaceutical & biotechnology companies, others) Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease, Others) and Regional Forecasts 2021-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Chemiluminescence Immunoassay Market, by Region, 2019-2027 (USD Billion)
1.2.2. Chemiluminescence Immunoassay Market, by Product, 2019-2027 (USD Billion)
1.2.3. Chemiluminescence Immunoassay Market, by End-use, 2019-2027 (USD Billion)
1.2.4. Chemiluminescence Immunoassay Market, by Application, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Chemiluminescence Immunoassay Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Chemiluminescence Immunoassay Market Dynamics
3.1. Chemiluminescence Immunoassay Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Introduction of novel technologies
3.1.1.2. CLIA has several features over other technologies
3.1.2. Market Challenges
3.1.2.1. These high-priced technologies are complicated to implement in developing countries
3.1.3. Market Opportunities
3.1.3.1. Technological advancements in rapid test
Chapter 4. Global Chemiluminescence Immunoassay Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Chemiluminescence Immunoassay Market, by Product
5.1. Market Snapshot
5.2. Global Chemiluminescence Immunoassay Market by Product, Performance - Potential Analysis
5.3. Global Chemiluminescence Immunoassay Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
5.4. Chemiluminescence Immunoassay Market, Sub Segment Analysis
5.4.1. Instruments
5.4.2. Consumables
5.4.3. Software & Services
Chapter 6. Global Chemiluminescence Immunoassay Market, by End-use
6.1. Market Snapshot
6.2. Global Chemiluminescence Immunoassay Market by End-use, Performance - Potential Analysis
6.3. Global Chemiluminescence Immunoassay Market Estimates & Forecasts by End-use 2018-2027 (USD Billion)
6.4. Chemiluminescence Immunoassay Market, Sub Segment Analysis
6.4.1. Hospitals
6.4.2. Clinical Laboratories
6.4.3. Pharmaceuticals & Biotechnology Companies
6.4.4. Others
Chapter 7. Global Chemiluminescence Immunoassay Market, by Application:
7.1. Market Snapshot
7.2. Global Chemiluminescence Immunoassay Market by Application, Performance - Potential Analysis
7.3. Global Chemiluminescence Immunoassay Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
7.4. Chemiluminescence Immunoassay Market, Sub Segment Analysis
7.4.1. Therapeutic Drug Monitoring
7.4.2. Oncology
7.4.3. Cardiology
7.4.4. Endocrinology
7.4.5. Infectious Disease
7.4.6. Autoimmune Disease
7.4.7. Others
Chapter 8. Global Chemiluminescence Immunoassay Market, Regional Analysis
8.1. Chemiluminescence Immunoassay Market, Regional Market Snapshot
8.2. North America Chemiluminescence Immunoassay Market
8.2.1. U.S. Chemiluminescence Immunoassay Market
8.2.1.1. Product breakdown estimates & forecasts, 2018-2027
8.2.1.2. End-use breakdown estimates & forecasts, 2018-2027
8.2.1.3. Application breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Chemiluminescence Immunoassay Market
8.3. Europe Chemiluminescence Immunoassay Market Snapshot
8.3.1. U.K. Chemiluminescence Immunoassay Market
8.3.2. Germany Chemiluminescence Immunoassay Market
8.3.3. France Chemiluminescence Immunoassay Market
8.3.4. Spain Chemiluminescence Immunoassay Market
8.3.5. Italy Chemiluminescence Immunoassay Market
8.3.6. Rest of Europe Chemiluminescence Immunoassay Market
8.4. Asia-Pacific Chemiluminescence Immunoassay Market Snapshot
8.4.1. China Chemiluminescence Immunoassay Market
8.4.2. India Chemiluminescence Immunoassay Market
8.4.3. Japan Chemiluminescence Immunoassay Market
8.4.4. Australia Chemiluminescence Immunoassay Market
8.4.5. South Korea Chemiluminescence Immunoassay Market
8.4.6. Rest of Asia Pacific Chemiluminescence Immunoassay Market
8.5. Latin America Chemiluminescence Immunoassay Market Snapshot
8.5.1. Brazil Chemiluminescence Immunoassay Market
8.5.2. Mexico Chemiluminescence Immunoassay Market
8.6. Rest of The World Chemiluminescence Immunoassay Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. DiaSorin S.p.A.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. End-use Summary
9.2.1.5. Recent Developments
9.2.2. Abbott Laboratories
9.2.3. Shenzhen Mindray Bio-medical Electronics Co. Ltd.
9.2.4. Immunodiagnostic Systems
9.2.5. Siemens Healthineers
9.2.6. Beckman Coulter Inc.
9.2.7. F. Hoffmann-La Roche AG
9.2.8. Inova Diagnostic Inc.
9.2.9. Maccura Biotechnology Co. Ltd.
9.2.10. Ortho Clinical Diagnostics
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption